Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL; International PACTG 316 Team.

JAMA. 2002 Jul 10;288(2):189-98.

PMID:
12095383
2.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.

N Engl J Med. 2002 Jun 13;346(24):1863-70.

3.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94.

PMID:
11981365
4.

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group Members.

HIV Clin Trials. 2001 Jan-Feb;2(1):56-91. No abstract available.

PMID:
11590515
5.

Understanding the timing of HIV transmission from mother to infant.

Kourtis AP, Bulterys M, Nesheim SR, Lee FK.

JAMA. 2001 Feb 14;285(6):709-12. No abstract available.

PMID:
11176886
6.

Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.

Mandelbrot L, Peytavin G, Firtion G, Farinotti R.

Am J Obstet Gynecol. 2001 Jan;184(2):153-8.

PMID:
11174495
7.

Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.

Rodman JH, Flynn PM, Robbins B, Jimenez E, Bardeguez AD, Rodriguez JF, Blanchard S, Fridland A.

J Infect Dis. 1999 Dec;180(6):1844-50.

8.

Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers.

Mandelbrot L, Burgard M, Teglas JP, Bénifla JL, Khan C, Blot P, Vilmer E, Matheron S, Firtion G, Blanche S, Mayaux MJ, Rouzioux C.

AIDS. 1999 Oct 22;13(15):2143-9.

PMID:
10546868
9.

Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.

Wang Y, Livingston E, Patil S, McKinney RE, Bardeguez AD, Gandia J, O'Sullivan MJ, Clax P, Huang S, Unadkat JD.

J Infect Dis. 1999 Nov;180(5):1536-41.

10.

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.

Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, Ciraru-Vigneron N, Lacroix C, Rouzioux C, Mandelbrot L, Desguerre I, Rötig A, Mayaux MJ, Delfraissy JF.

Lancet. 1999 Sep 25;354(9184):1084-9.

PMID:
10509500
11.

Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine.

Hanson IC, Antonelli TA, Sperling RS, Oleske JM, Cooper E, Culnane M, Fowler MG, Kalish LA, Lee SS, McSherry G, Mofenson L, Shapiro DE.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):463-7.

PMID:
10225228
13.

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J.

JAMA. 1999 Jan 13;281(2):151-7.

PMID:
9917118
14.

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring.

Moodley J, Moodley D, Pillay K, Coovadia H, Saba J, van Leeuwen R, Goodwin C, Harrigan PR, Moore KH, Stone C, Plumb R, Johnson MA.

J Infect Dis. 1998 Nov;178(5):1327-33.

15.

Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model.

Casey BM, Bawdon RE.

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):758-61.

PMID:
9757985
16.

In vivo maternal-fetal-amniotic fluid pharmacokinetics of zidovudine in the pigtailed macaque: comparison of steady-state and single-dose regimens.

Tuntland T, Odinecs A, Nosbisch C, Unadkat JD.

J Pharmacol Exp Ther. 1998 Apr;285(1):54-62. Erratum in: J Pharmacol Exp Ther 1998 Sep;286(3):1495.

17.
18.

Antiretroviral therapy for pregnant women.

Minkoff H, Augenbraun M.

Am J Obstet Gynecol. 1997 Feb;176(2):478-89. Review.

PMID:
9065202
19.

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL.

N Engl J Med. 1996 Nov 28;335(22):1621-9.

20.

Transfer and metabolism of dideoxyinosine by the perfused human placenta.

Dancis J, Lee JD, Mendoza S, Liebes L.

J Acquir Immune Defic Syndr. 1993 Jan;6(1):2-6.

PMID:
8417171
Items per page

Supplemental Content

Write to the Help Desk